Trade NNVC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
NanoViricides Inc. (NNVC) is trading at US$1.25, down 2.73% today as of Aug 28, 11:33 EDT. The company has a market capitalisation of US$33.91M. Over the past 52 weeks, NNVC has traded between US$0.85 and US$2.23. On Syfe you can trade NNVC with $0 commission and add it to your watchlist.
| Previous close | US$1.28 |
|---|---|
| Market cap | US$33.91M |
| 52-week range | US$0.85 – US$2.23 |
| Volume | 236.45K |
| Exchange | US |
Add to Watchlist
Set Price Alert
NanoViricides Inc.
NanoViricides, Inc. is a clinical stage company, which engages in the development of nano-biopharmaceutical drugs against viruses. It focuses on anti-viral therapeutics through internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
Year: 2005
NanoViricides Raises Financing for Trial of Ebola Treatment, Awaits Regulatory Approval in Congo
Jul 28, 1:03 PM · MT Newswires
NanoViricides Shares Fall Pre-Bell After $3.8 Million Direct Stock Sale Pricing
Jul 24, 12:50 PM · MT Newswires
NanoViricides Seeks Approval for Phase 2 Trial of NV-387 Oral Gummies to Treat Ebola in Congo
Jul 22, 1:35 PM · MT Newswires
NanoViricides Says Phase 2 Trial of NV-387 for Ebola Receives Ethics Approval in Congo
Jul 13, 2:16 PM · MT Newswires
NanoViricides Files for $50 Million Mixed Shelf Offering
Jun 5, 8:53 PM · MT Newswires
NanoViricides Inc. (NNVC) stock is trading at US$1.25, -2.73% from the previous close of US$1.28.
The market cap for NanoViricides Inc. (NNVC) stock is approximately US$33.91M.
The 52-week high for NanoViricides Inc. (NNVC) stock is US$2.23.
The 52-week low for NanoViricides Inc. (NNVC) stock is US$0.85.
NanoViricides Inc. (NNVC) does not currently pay a dividend.
Stay on top of NNVC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
